These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 7692684)

  • 1. Can one predict antigenic peptides for MHC class I-restricted cytotoxic T lymphocytes useful for vaccination?
    Calin-Laurens V; Trescol-Biémont MC; Gerlier D; Rabourdin-Combe C
    Vaccine; 1993; 11(9):974-8. PubMed ID: 7692684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
    Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
    Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of hen egg lysozyme-specific and major histocompatibility complex class I-restricted cytolytic T lymphocytes: recognition of cytosolic and secreted antigen expressed by transfected cells.
    Forquet F; Calin V; Trescol-Biemont MC; Kanellopoulos J; Mottez E; Kourilsky P; Rabourdin-Combe C; Gerlier D
    Eur J Immunol; 1990 Oct; 20(10):2325-32. PubMed ID: 2242761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-dominant restriction by a mixed-haplotype I-A molecule (alpha k beta b) for the lysozyme peptide 52-61 in H-2k x H-2b F1 mice.
    Moreno J; Adorini L; Hämmerling GJ
    J Immunol; 1990 May; 144(9):3296-304. PubMed ID: 1970351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of T-cell responses to peptides and lipopeptides with MHC class I binding motifs derived from the amino acid sequence of the 19-kDa lipoprotein of Mycobacterium tuberculosis.
    Fonseca DP; Joosten D; Snippe H; Verheul AF
    Mol Immunol; 2000 Jun; 37(8):413-22. PubMed ID: 11090876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes.
    Gairin JE; Mazarguil H; Hudrisier D; Oldstone MB
    J Virol; 1995 Apr; 69(4):2297-305. PubMed ID: 7533855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model.
    Gapin L; Bravo de Alba Y; Casrouge A; Cabaniols JP; Kourilsky P; Kanellopoulos J
    J Immunol; 1998 Feb; 160(4):1555-64. PubMed ID: 9469410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection.
    Oldstone MB; Lewicki H; Borrow P; Hudrisier D; Gairin JE
    J Virol; 1995 Dec; 69(12):7423-9. PubMed ID: 7494247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M; Pendleton CD; Berzofsky JA
    J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissection of H-2Db-restricted cytotoxic T-lymphocyte epitopes on simian virus 40 T antigen by the use of synthetic peptides and H-2Dbm mutants.
    Tevethia SS; Lewis M; Tanaka Y; Milici J; Knowles B; Maloy WL; Anderson R
    J Virol; 1990 Mar; 64(3):1192-200. PubMed ID: 1689391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity.
    Feltkamp MC; Vierboom MP; Kast WM; Melief CJ
    Mol Immunol; 1994 Dec; 31(18):1391-401. PubMed ID: 7823965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin D, but not cathepsin B, releases T cell stimulatory fragments from lysozyme that are functional in the context of multiple murine class II MHC molecules.
    van Noort JM; Jacobs MJ
    Eur J Immunol; 1994 Sep; 24(9):2175-80. PubMed ID: 8088334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
    Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
    J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a nonameric H-2Kk-restricted CD8+ cytotoxic T lymphocyte epitope on the Plasmodium falciparum circumsporozoite protein.
    Malik A; Houghten R; Corradin G; Buus S; Berzofsky JA; Hoffman SL
    Infect Immun; 1995 May; 63(5):1955-9. PubMed ID: 7537251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of viral antigens to major histocompatibility complex class I H-2Db molecules is controlled by dominant negative elements at peptide non-anchor residues. Implications for peptide selection and presentation.
    Hudrisier D; Mazarguil H; Laval F; Oldstone MB; Gairin JE
    J Biol Chem; 1996 Jul; 271(30):17829-36. PubMed ID: 8663374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide vaccination with an anchor-replaced CTL epitope protects against human papillomavirus type 16-induced tumors expressing the wild-type epitope.
    Vierboom MP; Feltkamp MC; Neisig A; Drijfhout JW; ter Schegget J; Neefjes JJ; Melief CJ; Kast WM
    J Immunother; 1998 Nov; 21(6):399-408. PubMed ID: 9807734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.
    Leighton J; Sette A; Sidney J; Appella E; Ehrhardt C; Fuchs S; Adorini L
    J Immunol; 1991 Jul; 147(1):198-204. PubMed ID: 1711074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First glimpse of the peptide presentation by rhesus macaque MHC class I: crystal structures of Mamu-A*01 complexed with two immunogenic SIV epitopes and insights into CTL escape.
    Chu F; Lou Z; Chen YW; Liu Y; Gao B; Zong L; Khan AH; Bell JI; Rao Z; Gao GF
    J Immunol; 2007 Jan; 178(2):944-52. PubMed ID: 17202356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.